The United States is poised to see its centenarian population—people who have reached 100 years of age—shrink into the realm of the common. Census Bureau projections released by the Pew Research Center in January 2024 estimate that the number of Americans aged 100 or older will climb from roughly 101,000 in 2024 to about 422,000 by 2054. That jump would raise the share of centenarians from 0.03 % of the population to 0.1 %. The trend mirrors a worldwide surge that has taken the global count from 722,000 in 2024 to an expected 4 million by 2054.

The United States’ centenarian story is a tale of acceleration. In 1950, the Census Bureau counted only about 2,300 Americans who had reached the century mark—roughly one in 66,000 people. By 1990 the figure had ballooned to 37,000, and the 2020 count reached 92,000. The 2024 estimate of just over 101,000 represents a 10 % rise in a single year, a growth driven by a larger cohort of 90‑year‑olds and a continued decline in mortality among that age group.

What fuels this rise is not a dramatic drop in death rates for younger or middle‑aged cohorts—whose mortality is already low—but a steady fall in death rates among nonagenarians. Each successive cohort of people aged 90 to 99 has lived a touch longer than the previous one, raising the proportion of any birth cohort that eventually turns 100. The effect is amplified by the rapid increase in the number of 90‑year‑olds in the United States.

On the world stage, the United Nations recorded 722,000 centenarians in 2024 and projects 4 million by 2054. China is projected to have the largest national centenarian population at about 767,000, followed by the United States at 422,000, and then India, Japan, and Thailand. Japan, already the world’s oldest country, is expected to reach 40 centenarians per 10,000 residents by 2054, while Thailand is projected to hit 49 per 10,000.

Demographers are divided on how far these numbers will climb and how quickly a majority of births in low‑mortality countries will produce people who eventually reach 100. The optimistic view, championed by James Vaupel and colleagues at the Max Planck Institute, holds that life expectancy has increased by about three months per year for the past 150 years and shows no sign of slowing. Under that scenario, most children born today in advanced countries would eventually reach their hundredth birthday.

The skeptical perspective, led by S. Jay Olshansky and collaborators, argues that gains in life expectancy are now slowing. In the United States, life expectancy peaked at 78.9 years in 2014 and has since declined to about 76 years, a trend attributed to the opioid crisis, rising obesity, COVID‑19 mortality, and plateauing advances in cardiovascular medicine. The higher‑end centenarian projections rely on the assumption that the recent slowdown is temporary and that the long‑term trajectory will resume.

The question of a maximum human lifespan also ties into the centenarian trend. A 2021 Bayesian analysis by Michael Pearce and Adrian Raftery of the University of Washington modeled the distribution of supercentenarians—those who live past 110—and projected that there is a greater than 99 % probability that the current record lifespan, Jeanne Calment’s 122 years and 164 days, will be broken before 2100. The model estimates an 89 % probability that someone will reach 126, a 44 % probability for 128, and a 13 % probability for 130.

While longevity is rising, healthspan—the proportion of life spent in good health—has been growing more slowly. The widening gap means that more people will spend longer periods in disability, cognitive decline, or dependence on caregivers. The economic implications are significant: pension systems, health care, and family structures built on earlier assumptions about life expectancy and post‑retirement years may become misaligned with reality.

In short, the United States and the world are entering a new era of aging in which centenarians will become a substantial demographic group. The pace and magnitude of this change will depend on whether mortality improvements at older ages continue, accelerate, or plateau, and on how healthspan evolves alongside lifespan.